The novel treatment of tirzepatide peptide represents a exciting development in the management of type 2 diabetes. Unlike existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide734103.alltdesign.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-60749716